• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

1508250-71-2 (EGF816)

1

Identification

EGF816 EGF816
Name EGF816
Formula C26H31ClN6O2
MW 495.02
CAS No. 1508250-71-2
EINECS
Smiles O=C(C1=CC(C)=NC=C1)NC2=NC3=CC=CC(Cl)=C3N2[[email protected]]4CN(C(/C=C/CN(C)C)=O)CCCC4
Synonyms EGF-816;Nazartinib; (R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide
InChI InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1
2

Introduction

EGF816 is a novel covalent inhibitor of mutant-selective EGFR; overcomes T790M-mediated resistance in NSCLC.

Background Information

EGF816 is a novel covalent inhibitor of mutant-selective EGFR; overcomes T790M-mediated resistance in NSCLC. ......by MedChemexpress Co., Ltd.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white Solid EBNumber:EB000070803

Storage condition

4°C by MedChemexpress Co., Ltd.

Solubility

10 mM in DMSO by CHEMSCENE, LLC
10 mM in DMSO by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways JAK/STAT Signaling Protein Tyrosine Kinase/RTK
Target EGFR
Research Area Cancer
Indications NSCLC Non Small Cell Lung Cancer
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
EGF816 Novartis Pharmaceuticals NSCLC 2014/4/7 Phase 2
EGF816 Novartis Pharmaceuticals Non Small Cell Lung Cancer 2014/12/18 Phase 2
EGF816 - Phase 2 Clinical
7

Safety Data of EGF816

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
CHEMSCENE, LLC USA
MedChemexpress Co., Ltd. 5mg/USD350(In stock);10mg/USD500(In stock);50mg/USD1500(In stock);100mg/USD2100(In stock) USA
Shanghai Haoyuan Chemexpress Co., Ltd. China
10

Related Products

Other Forms of 1508250-71-2

Name CAS No Formula MW
EGF816 (S enantiomer) 1508256-20-9 C26H31ClN6O2 495.02
EGF816 (mesylate) 1508250-72-3 C27H35ClN6O5S 591.12

Recommended Compounds in EGFR

Name CAS No Formula MW
Ginsenoside Rh2 78214-33-2 C36H62O8 622.87
Mutated EGFR-IN-1 1421372-66-8 C25H31N7O 445.56
AZD-9291 (mesylate) 1421373-66-1 C29H37N7O5S 595.71
Mutant EGFR inhibitor 1421373-62-7 C27H30ClN7O2 520.03
AZD-9291 1421373-65-0 C28H33N7O2 499.61
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 333.77
WHI-P180 211555-08-7 C16H15N3O3 297.31
Gefitinib (hydrochloride) 184475-55-6 C22H25Cl2FN4O3 483.36
Erlotinib (mesylate) 248594-19-6 C23H27N3O7S 489.54
BGB-102 807640-87-5 C22H25BrN4O2 457.36
Poziotinib 1092364-38-9 C23H21Cl2FN4O3 491.34
CO-1686 (hydrobromide) 1446700-26-0 C27H29BrF3N7O3 636.46
CO-1686 1374640-70-6 C27H28F3N7O3 555.55
CNX-2006 1375465-09-0 C26H27F4N7O2 545.53
PD 168393 194423-15-9 C17H13BrN4O 369.22
AG 18 118409-57-7 C10H6N2O2 186.17
Afatinib (dimaleate) 850140-73-7 C32H33ClFN5O11 718.08
Chrysophanic acid 481-74-3 C15H10O4 254.24
AG-1478 153436-53-4 C16H14ClN3O2 315.75
Mubritinib 366017-09-6 C25H23F3N4O2 468.47

Recommended Compounds in Same Indication

Name CAS No Formula MW
EGF816 (mesylate) 1508250-72-3 C27H35ClN6O5S 591.12
AZD-9291 1421373-65-0 C28H33N7O2 499.61
11

Route of Synthesis

12

References

13

More Information

EGF816

Tags: buy 1508250-71-2 IC50 | 1508250-71-2 price | 1508250-71-2 cost | 1508250-71-2 solubility | 1508250-71-2 purchase | 1508250-71-2 manufacturer | 1508250-71-2 research buy | 1508250-71-2 order | 1508250-71-2 MSDS | 1508250-71-2 chemical structure | 1508250-71-2 Storage condition | 1508250-71-2 molecular weight | 1508250-71-2 mw | 1508250-71-2 datasheet | 1508250-71-2 supplier | 1508250-71-2 cell line | 1508250-71-2 NMR | 1508250-71-2 MS | 1508250-71-2 IR | 1508250-71-2 solubility | 1508250-71-2 Safe information | 1508250-71-2 Qc and Spectral Information | 1508250-71-2 Clinical Information | 1508250-71-2 Clinical Trial | 1508250-71-2 Route of Synthesis | 1508250-71-2 storage condition | 1508250-71-2 diseases and conditions | 1508250-71-2 flash point | 1508250-71-2 boiling point | 1508250-71-2 melting point | 1508250-71-2 storage condition | 1508250-71-2 brand